Biohaven Corp (BHVN): Rasio kapitalisasi marang pendapatan
Geopolitical tensions are limiting the export of neurological drugs, yet stable laboratory operations and capacity modernization are offsetting these risks. The historical P/S trend on the GURU.Markets terminal chart smooths out reporting noise, where the 1.40 value serves as the baseline valuation metric. The fundamentals of Biohaven Ltd. (BHVN) are based on the experience of the Nurtec creators and an innovative approach to treating severe CNS pathologies.
Rincian analitis perusahaan Biohaven Pharmaceutical (BHVN)
- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi bursa:
- rincian valuasi buku bisnis:
- rincian struktur utang lan likuiditas bisnis:
Utang Agregat marang Modal Biohaven Ltd.|BHVN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal Biohaven Corp|BHVN - Gunggung utang perusahaan|Utang-utang marang aset resik Biohaven Pharmaceutical|BHVN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Biohaven|Rasio jangkoan perantara biohavenpharma.com
- informasi bathi lan kelipatan valuasi:
BHVN - Penghasilan resik|Bathi sing dikarepake Biohaven Ltd.|BHVN - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Biohaven Ltd|BHVN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Biohaven Pharmaceutical|BHVN - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Biohaven|BHVN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan biohavenpharma.com|BHVN - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Biohaven Ltd.
- data total pendapatan lan volume dodolan:
Ringkesan analitik perusahaan:BHVN, biohavenpharma.com
A stable staff of neurobiologists and the absence of talent attrition at Biohaven Ltd. (BHVN) create a foundation for long-term sales growth, which directly capitalizes into the market value of the shares. By analyzing the current price-to-sales ratio, an investor assesses how many dollars of market value are attributed to one dollar of sales, making it possible to identify if the asset is overbought relative to its historical averages.
Perusahaan pesaing
BIIB - Rega marang dodolan|Rasio rega marang pendapatan Neurocrine Biosciences, Inc. NBIX|RGC: Rasio kapitalisasi marang pendapatan|AXSM: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ACAD (ACADIA Corp)|Xenon Pharmaceuticals (XENE) - Rasio rega marang pendapatan|VKTX (vikingtherapeutics.com) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan SUPN|CPRX (Catalyst Pharma) - Kapitalisasi marang volume dodolan|Multiplikator P/S DNLI|Harmony Corp - Rasio kapitalisasi marang pendapatan|Amylyx Pharmaceuticals - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan trevitherapeutics.com (TRVI)|Praxis Precision Medicines, Inc. - Multiplikator P/S|AVXL: Rasio rega marang pendapatan|CBLL: Multiplikator P/S|Prothena Corp - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan ALEC|Rasio rega marang pendapatan ANNX|Rasio rega marang pendapatan Omeros Corporation (OMER)|Neurogene Inc - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan AC Immune Corp ACIU|VYGR: Rasio kapitalisasi marang pendapatan|Neumora Therapeutics - Multiplikator P/S|Rega marang dodolan scilexholding.com|TVGN (Tevogen Bio) - Kapitalisasi marang pendapatan|Alpha Cognition Inc. (ACOG) - Multiplikator P/S|Rasio rega marang pendapatan Cognition Therapeutics, Inc.|IKT: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Cassava Sciences, Inc. (SAVA)|ASRT - Rega marang dodolan|Multiplikator P/S COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. - Rasio rega marang pendapatan|Ovid Rx - Multiplikator P/S|Koefisien rega marang pendapatan Acumen Pharmaceuticals, Inc ABOS|CervoMed Inc. (CRVO) - Rasio rega marang pendapatan|Rega marang dodolan Alterity Therapeutics Limited (ATHE)|CLNN (Clene Inc) - Multiplikator P/S|PEPG: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S JUNS|Multiplikator P/S Relmada Corp (RLMD)|Annovis Bio, Inc. - Kapitalisasi marang pendapatan|Grace Therapeutics Inc - Rasio rega marang pendapatan|Firefly Neuroscience - Multiplikator P/S|Rega marang dodolan Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan RVPH|Kapitalisasi marang pendapatan MTVA|NRXS: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Helius Medical (HSDT)|Rasio rega marang pendapatan PASG (passagebio.com)|Neuphoria Therapeutics - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan NERV (Minerva)|Athira Pharma, Inc. - Multiplikator P/S|ADXN (addextherapeutics.com) - Rasio kapitalisasi marang pendapatan|ALZN (alzamend.com) - Kapitalisasi marang pendapatan|CYCN - Koefisien rega marang pendapatan|PTIX (Protagenic Therapeutics Inc.) - Multiplikator P/S|Rasio rega marang pendapatan KTTA|Multiplikator P/S CRGT|ATXI (avenuetx.com) - Rasio kapitalisasi pasar marang pendapatan|BrainStorm Cell Therapeutics - Kapitalisasi marang pendapatan|Cara Therapeutics Inc. - Rasio rega marang pendapatan|CHRO - Rasio rega marang pendapatan|ELYM (Eliem Therapeutics) - Rasio kapitalisasi marang pendapatan|intracellulartherapies.com (ITCI) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan LBPH|MRNS (Marinus Pharmaceuticals, Inc.) - Multiplikator P/S|Rega marang dodolan NKGen Biotech Inc NKGN|Kapitalisasi marang pendapatan NRBO (NeuroBo)|Multiplikator P/S Sage Therapeutics Inc (SAGE)|Rasio rega marang pendapatan Synaptogenix, Inc. SNPX|Rasio kapitalisasi pasar marang pendapatan TRVN|VIGL - Rasio rega marang pendapatan|Rega marang dodolan anewmeds.com|CERE: Multiplikator P/S
